Gevo Inc (NASDAQ: GEVO): Hunting Genuine Value In Market Debris
Currently, there are 239.41M common shares owned by the public and among those 227.15M shares have been available to trade. The company’s stock has a 5-day price change of -24.56% and 12.57% over the past three months. GEVO shares are trading 2.87% year to date (YTD), with the 12-month market performance up to 106.73% higher. […]
Why Should You Put Albertsons Companies Inc (NYSE: ACI) On Your Portfolio?
Currently, there are 579.36M common shares owned by the public and among those 420.04M shares have been available to trade. The company’s stock has a 5-day price change of 4.34% and 12.90% over the past three months. ACI shares are trading 5.19% year to date (YTD), with the 12-month market performance down to -10.37% lower. […]
Growing Through Challenges? – Kinder Morgan Inc (KMI)
Currently, there are 2.22B common shares owned by the public and among those 1.94B shares have been available to trade. The company’s stock has a 5-day price change of 0.88% and 20.24% over the past three months. KMI shares are trading 4.09% year to date (YTD), with the 12-month market performance up to 58.89% higher. […]
Do Astrazeneca plc ADR (NASDAQ: AZN) Fit In A Value Investing Philosophy?
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -0.78% and -14.49% over the past three months. AZN shares are trading 0.32% year to date (YTD), with the 12-month market performance down to -5.52% lower. […]
Sempra (NYSE: SRE): The Best-Of-Breed For Investing?
Currently, there are 633.21M common shares owned by the public and among those 633.02M shares have been available to trade. The company’s stock has a 5-day price change of -12.24% and -5.40% over the past three months. SRE shares are trading -12.29% year to date (YTD), with the 12-month market performance up to 1.06% higher. […]
Sage Therapeutics Inc (SAGE) Testing Investors’ Patience Right Now
Currently, there are 61.17M common shares owned by the public and among those 53.88M shares have been available to trade. The company’s stock has a 5-day price change of 22.15% and 17.74% over the past three months. SAGE shares are trading 38.12% year to date (YTD), with the 12-month market performance down to -70.47% lower. […]
Analyst Expect Big Moves From Agilon Health Inc (NYSE: AGL)
Currently, there are 411.96M common shares owned by the public and among those 303.29M shares have been available to trade. The company’s stock has a 5-day price change of 37.80% and -13.25% over the past three months. AGL shares are trading 51.58% year to date (YTD), with the 12-month market performance down to -63.91% lower. […]
Annaly Capital Management Inc (NYSE: NLY) Hogging The Spotlight Today
Currently, there are 560.55M common shares owned by the public and among those 559.51M shares have been available to trade. The company’s stock has a 5-day price change of -4.53% and -8.58% over the past three months. NLY shares are trading -0.98% year to date (YTD), with the 12-month market performance down to -7.12% lower. […]
Reviewing The Case For Under Armour Inc (UAA) Going Higher
Currently, there are 188.82M common shares owned by the public and among those 188.24M shares have been available to trade. The company’s stock has a 5-day price change of -0.72% and -0.72% over the past three months. UAA shares are trading 0.24% year to date (YTD), with the 12-month market performance down to -0.84% lower. […]
Is Esperion Therapeutics Inc (NASDAQ: ESPR) Back In The Buying Zone?
Currently, there are 195.44M common shares owned by the public and among those 195.08M shares have been available to trade. The company’s stock has a 5-day price change of 4.11% and 20.63% over the past three months. ESPR shares are trading 3.64% year to date (YTD), with the 12-month market performance down to -17.09% lower. […]
